Fiona Marshall, co-founder and chief scientific officer of Heptares Therapeutics, part of Sosei Group Corp, has been elected a Fellow of The Academy of Medical Sciences for her contribution to the advancement of medical science. Dr Marshall has more than 25 years of experience in the field of structure-based drug design with particular expertise in G protein-coupled receptors. She is the inventor of seven patents and the author or more than 80 peer-reviewed science papers in this area. Her work has contributed to the discovery of drugs in development for cancer, schizophrenia, Alzheimer’s disease and migraine.
Prior to Heptares, Dr Marshall worked in senior drug discovery roles at GlaxoWellcome, GlaxoSmithKline and Millennium Pharmaceuticals Inc. She received a BSc in biochemistry from Bath University and a PhD in neuroscience from Cambridge University.
Heptares announced the election on 28 April 2016.
Copyright 2016 Evernow Publishing Ltd